AUSTRALIA’S life sciences and healthcare industry is set to become a key growth sector for DHL Global Forwarding in the coming years.
The global logistics provider has boosted its capabilities in recent years, including establishing three main facilities in Australia that adhere to the European Union’s Good Distribution Practice guidelines for life sciences and healthcare supply chains.
At the inaugural conference in Sydney recently, DHL representatives and customers discussed the future of the sector and how digitisation and technology, such as big data analytics and Internet of Things, are transforming supply chains.
“Longer life expectancies, prevalence of chronic diseases, and a growing middle class has led to an increase in global demand for healthcare products and services,” Charles Kaufmann, CEO – DHL Global Forwarding North Asia/South Pacific and President/Representative Director – DHL Global Forwarding Japan K.K, said.
“Key sector trends such as precision medication and tighter regulations are equally compounding the need for a competent and compliant logistics infrastructure to support the evolution of the industry.”
The DHL Air Thermonet and DHL Ocean Thermonet temperature controlled freight solutions meet global industry standards in shipping products ranging from over-the-counter pharmaceutical drugs to medical equipment.